0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Dermatology |

Highlights FREE

JAMA Dermatol. 2014;150(1):3. doi:10.1001/jamadermatol.2013.6515.
Text Size: A A A
Published online

RESEARCH

Nodal metastases from cutaneous squamous cell carcinoma (cSCC) are rare. Identifying patients at greatest risk remains a challenge because clear prognostic data are lacking. In this case series, Schmitt et al evaluate patients with nonanogenital cSCC having sufficient tumor characteristics to allow staging and who underwent sentinel lymph node (SLN) biopsy. A positive SLN was found in 12.3% of patients, mostly in those with T2 lesions. Sentinel lymph node biopsy accurately identifies SLNs and is well tolerated, although the survival benefit of early detection of subclinical nodal metastases is unknown.

Related Editorial

Bullous pemphigoid (BP) is the most common cutaneous autoimmune blistering disease. BP autoantibodies target 2 hemidesmosomal proteins of the basement membrane zone, BP180 and BP230. Anti-BP 180 autoantibodies are detected in many BP cases, and serum levels correlate with disease activity. In this multicenter prospective study of consecutive BP cases, Fichel and colleagues demonstrated that superpotent topical corticosteroids alone produced a marked decrease in anti-BP 180 autoantibodies in most patients, corresponding with an early therapeutic response. In addition, dementia and extensive initial disease were independent risk factors for BP relapse during the first year of treatment. In an Invited Commentary, Fine discusses the findings in the context of previous research.

Many members of melanoma families exhibit atypical nevi, and the presence of multiple atypical nevi implies a higher risk of carrying a mutation in a melanoma-predisposing gene. In this 20-year follow-up study of children from familial melanoma families, Vredenborg and colleagues demonstrated that the number and distribution of melanocytic nevi were major indicators of risk of melanoma. Nevi 5 mm or larger on the buttock were particularly associated with a higher lifetime risk of melanoma.

Neurofibromatosis type 1 (NF1) is a hereditary autosomal dominant condition that occurs in 1 in 3500 births. The diagnosis of NF1 is made on the basis of 7 clinical criteria, but these are often of limited value before the age of 2 years. In this retrospective medical record review of patients with NF1, Ferrari and colleagues found a high prevalence of juvenile xanthogranuloma and nevus anemicus among patients with NF1 younger than 2 years. Although the prevalence of juvenile xanthogranuloma and nevus anemicus in the general population is not precisely known, they are certainly much less frequent. Thus, both cutaneous signs appear as good criteria for NF1 diagnosis in infancy and early childhood.

To determine the impact of social media in dermatology, Amir and colleagues evaluated the social media presence of current dermatology journals as well as professional and patient-centered dermatology organizations. Although some journals were found to be active in social media, most lagged behind patient-centered and professional dermatology organizations. With continued technological evolution, organizations that fail to recognize the opportunities provided by social networking sites may risk becoming marginalized by their inability to assimilate social media as an expected form of communication.

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

760 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs